Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma.

Laura Cappelli, Fredrick M Wigley

Journal: Rheumatic diseases clinics of North America 2016;41(3):419-38

PMID: 26210127

Full Text on Elsevier Science View on PubMed

Abstract

Raynaud phenomenon (RP) and associated digital ischemia can be among the most vexing clinical problems for patients with systemic sclerosis (scleroderma). Understanding the treatment approach to RP and associated ischemia and how to prevent digital ulcers is important for clinicians caring for these patients. This article reviews the management of RP and digital ischemic ulcers. The magnitude of the problem and pathophysiology of RP are first discussed, with an emphasis on recent advances in understanding of the disease process. Options for the practical pharmacologic and nonpharmacologic interventions for RP and digital ischemic ulcers are detailed.

Address: Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Suite 4100, Mason F. Lord Building, Center Tower, Baltimore, MD 21224, USA.; Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Suite 4100, Mason F. Lord Building, Center Tower, Baltimore, MD 21224, USA. Electronic address: [email protected].

DOI: 10.1016/j.rdc.2015.04.005

Link outs

Free resources

Medical:

https://medlineplus.gov/raynaudphenomenon.html

Subscription / membership required

Full Text Sources:

MeSH Terms: Adult, Female, Fingers, Humans, Raynaud Disease, Scleroderma, Systemic, Ulcer